Nika Pharmaceuticals, Inc (NIKA) stock
NIKAOTCPharmaceutical PreparationsFiscal year ends December 31
$0.41+0.00 (0.00%)
Close on Oct 16, 2026Market cap $431.19MP/E –Yield –
Nika Pharmaceuticals total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Nika Pharmaceuticals's total debt was $340.62K at Jun 30, 2026. For fiscal 2025 it was $318.62K, up 33.2% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $318.62K | +33.2% |
| FY2024 | Dec 31, 2024 | $239.16K | +135.1% |
| FY2023 | Dec 31, 2023 | $101.75K | +459.7% |
| FY2022 | Dec 31, 2022 | $18.18K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $340.62K | +19.9% |
| Q1 FY2026 | Mar 31, 2026 | $331.62K | +23.2% |
| Q4 FY2025 | Dec 31, 2025 | $318.62K | +33.2% |
| Q3 FY2025 | Sep 30, 2025 | $284.16K | +35.2% |
| Q2 FY2025 | Jun 30, 2025 | $284.16K | +10.7% |
| Q1 FY2025 | Mar 31, 2025 | $269.16K | +164.5% |
| Q4 FY2024 | Dec 31, 2024 | $239.16K | +178.9% |
| Q3 FY2024 | Sep 30, 2024 | $210.16K | +177.5% |
| Q1 FY2024 | Mar 31, 2024 | $256.62K | +520.7% |
| Q4 FY2023 | Dec 31, 2023 | $101.75K | +459.7% |
| Q3 FY2023 | Sep 30, 2023 | $85.75K | – |
| Q2 FY2023 | Jun 30, 2023 | $75.75K | – |
| Q1 FY2023 | Mar 31, 2023 | $41.35K | – |
| Q4 FY2022 | Dec 31, 2022 | $18.18K | – |
See a number that looks wrong?